Clinical trial
A Study of Zemplar® Injection and Hectorol® Injection on Intestinal Absorption…
NCT00257920 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00257920 |
|---|---|
| Title | A Study of Zemplar® Injection and Hectorol® Injection on Intestinal Absorption of Calcium in Chronic Kidney Disease |
| Official title | A Phase 4, Single-Center, Open-Label, Randomized, Active-Controlled, Cross-over Pilot Study to Evaluate the Effects of Two Vitamin D Analogs, Zemplar® Injection and Hectorol® Injection, on Intestinal Absorption of Calcium in CKD Stage 5 Subjects on Hemodialysis |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Chronic Kidney Disease, Stage 5, Secondary Hyperparathyroidism |
| Intervention type | Drug |
| Interventions | Zemplar® injection, Hectorol® injection |
| Enrollment | 41 |
| Start date | Jun 1, 2006 |
| Primary completion | Jan 1, 2008 |
| First posted | Nov 24, 2005 |
| Last update posted | Dec 24, 2009 |
| Countries | United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: